Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
Albertson
Peter C
PC
D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D009367:Neoplasm Staging; D019370:Observation / Q000379:methods; D018579:Patient Selection; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D013997:Time Factors
D017430:Prostate-Specific Antigen